A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Clinical trial NCT02152631 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02152631
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-03
- Primary completion
- 2017-09-15
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.